{"transactions":[{"id":4507,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:25:26.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":453,"price":3.0372,"value":1375.8516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":13839,"source":{"system":"sec-edgar","filing":"0002063082-26-000006","document":"wk-form4_1788553522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063082/000206308226000006/wk-form4_1788553522.xml","form_type":"4"}},{"id":695263,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:07:57.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":678,"price":2.58,"value":1749.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax  withholding obligations as a result of vesting in restricted stock units on August 1, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":14292,"source":{"system":"sec-edgar","filing":"0002063082-26-000003","document":"wk-form4_1785960474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000206308226000003/wk-form4_1785960474.xml","form_type":"4"}},{"id":747457,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T20:33:31.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":464,"price":2.701,"value":1253.264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7049. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14970,"source":{"system":"sec-edgar","filing":"0001650664-26-000057","document":"wk-form4_1780691609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000057/wk-form4_1780691609.xml","form_type":"4"}},{"id":841088,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option (right to  buy)","published_at":"2026-03-16T20:35:51.000Z","date":"2026-03-12","kind":"grant","planned":true,"acquired":true,"shares":292856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030."}],"balance_after":292856,"derivative":{"exercise_price":2.54,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":292856},"source":{"system":"sec-edgar","filing":"0001650664-26-000022","document":"wk-form4_1773693348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000022/wk-form4_1773693348.xml","form_type":"4"}},{"id":860634,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:49:20.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":474,"price":2.02,"value":957.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15434,"source":{"system":"sec-edgar","filing":"0001650664-26-000007","document":"wk-form4_1772660958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000007/wk-form4_1772660958.xml","form_type":"4"}},{"id":979969,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:38:06.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":461,"price":2.1531,"value":992.5791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":15908,"source":{"system":"sec-edgar","filing":"0001650664-25-000161","document":"wk-form4_1764884284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000161/wk-form4_1764884284.xml","form_type":"4"}},{"id":1047525,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T20:20:48.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":458,"price":2.5961,"value":1189.0138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":16369,"source":{"system":"sec-edgar","filing":"0001650664-25-000142","document":"wk-form4_1757017244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000142/wk-form4_1757017244.xml","form_type":"4"}},{"id":1071068,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-08T20:28:02.000Z","date":"2025-08-07","kind":"sale","planned":true,"acquired":false,"shares":679,"price":2.58,"value":1751.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":16827,"source":{"system":"sec-edgar","filing":"0001650664-25-000118","document":"wk-form4_1754684878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000118/wk-form4_1754684878.xml","form_type":"4"}},{"id":1122362,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T22:39:21.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":446,"price":1.724,"value":768.904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17506,"source":{"system":"sec-edgar","filing":"0001650664-25-000093","document":"wk-form4_1749076755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000093/wk-form4_1749076755.xml","form_type":"4"}},{"id":1175176,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10091,"kind":"person","name":"Parison Amy","position":1,"cik":"0002063082","reported_name":"Parison Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Stock Option (right to  buy)","published_at":"2025-04-08T20:29:42.000Z","date":"2025-04-08","kind":"grant","planned":false,"acquired":true,"shares":34672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly  monthly installments thereafter through April 8, 2029."}],"balance_after":34672,"derivative":{"exercise_price":0.98,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":34672},"source":{"system":"sec-edgar","filing":"0001650664-25-000052","document":"wk-form4_1744144175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000052/wk-form4_1744144175.xml","form_type":"4"}}]}